Results 81 to 90 of about 4,413 (107)

SNHG7 interacts with PCBP2 to promote CDKN2A expression and modulate cuproptosis in colorectal cancer. [PDF]

Transl Oncol
Chen Q, Song Q, Zhang H, Lin Z, Shi Y, Chai Y, Fang X, Li N, Zheng Y, Yang Y, Wu X, Wang S, He C, Li M.   +13 more
europepmc   +1 more source

Nanomedicine leverages cuproptosis-mediated cGAS-STING activation to enhance antitumor immunity. [PDF]

J Nanobiotechnology
Li C, Li Y, Wang Z, Wang Y, Guan W, Huang Z.   +5 more
europepmc   +1 more source

Nuclear accumulation of PANK4 in hippocampal astrocytes aggravates cuproptosis in association with mild cognitive impairment in aged mice. [PDF]

Front Aging Neurosci
Wang B, Zhang J, Li CH, Huang X, Gao RB, Peng Y, Xie Q, Ning YL, Zhao Y, Yang N, Chen X, Xie YL, Zhou YG, Lin S, Chen L, Li P.   +15 more
europepmc   +1 more source

Carrier-free GSH-responsive <i>in situ</i> nanoreactor for copper-overload augment cuproptosis/chemodynamic therapy. [PDF]

Mater Today Bio
Hu Y, Zhou Q, Wen H, Huang T, Liu Y, Liu Y, Jin X, Lu X, Wu H.   +8 more
europepmc   +1 more source

A new cuproptosis-associated lncRNA signature predicts the prognosis of clear cell renal cell carcinoma patients. [PDF]

Discov Oncol
He M, Hu W, Guan Y, Shu W, Leng Y, Zhu H, Yang K.   +6 more
europepmc   +1 more source

Pan‐cancer analyses reveal molecular and clinical characteristics of cuproptosis regulators

iMeta, 2023
Changwu Wu, Chaoying Qin, Wenyong Long   +2 more
exaly  

An Enzyme‐Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis‐Based Synergistic Cancer Therapy

Advanced Materials, 2022
Yuzhi Xu, Si-Yang Liu, Leli Zeng
exaly  

Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer Immunotherapy

Advanced Materials, 2023
Boda Guo, Feiya Yang, Haihua Xiao
exaly